{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:21:45Z","timestamp":1767147705063,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/j.jash.2014.03.329","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000}}],"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ashjournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Hypertension"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.jash.2014.03.329","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T16:31:08Z","timestamp":1396629068000},"page":"422-428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["RETRACTED: Enalapril\/lercanidipine combination on markers of cardiovascular risk: a randomized study"],"prefix":"10.1016","volume":"8","author":[{"given":"Giuseppe","family":"Derosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Bonaventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucio","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Fogari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"D'Angelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Maffioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jash.2014.03.329_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2014.03.329_bib2","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1185\/03007995.2012.717527","article-title":"Evaluation of emerging biomarkers in cardiovascular risk stratification of hypertensive patients: a 2-year study","volume":"28","author":"Derosa","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jash.2014.03.329_bib3","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1001\/jama.1992.03480240088040","article-title":"Lipoprotein(a). A genetic risk factor for premature coronary heart disease","volume":"267","author":"Scanu","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2014.03.329_bib4","first-page":"65","article-title":"Plasma lipoprotein (a) levels in patients with untreated essential hypertension","volume":"9","author":"Bhavani","year":"2003","journal-title":"Indian J Hum Genet"},{"key":"10.1016\/j.jash.2014.03.329_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/sj.jhh.1000540","article-title":"Lp(a) in hypertensive patients","volume":"12","author":"Catalano","year":"1998","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jash.2014.03.329_bib6","first-page":"1699","article-title":"Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues","volume":"143","author":"Brett","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jash.2014.03.329_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0169-328X(99)00174-6","article-title":"cDNA cloning of a novel secreted isoform of the human receptor for advanced glycation end products and characterization of cells co-expressing cell-surface scavenger receptors and Swedish mutant amyloid precursor protein","volume":"71","author":"Malherbe","year":"1999","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.jash.2014.03.329_bib8","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/01.ATV.0000160342.20342.00","article-title":"Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men","volume":"25","author":"Falcone","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jash.2014.03.329_bib9","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1161\/01.ATV.0000190660.32863.cd","article-title":"Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis","volume":"25","author":"Koyama","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jash.2014.03.329_bib10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2174\/187152908785849125","article-title":"Soluble CD40L and its role in essential hypertension: diagnostic and therapeutic implications","volume":"8","author":"Ferroni","year":"2008","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"10.1016\/j.jash.2014.03.329_bib11","doi-asserted-by":"crossref","first-page":"37524","DOI":"10.1074\/jbc.275.48.37524","article-title":"Nitric oxide is a physiological substrate for mammalian peroxidases","volume":"275","author":"Abu-Soud","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jash.2014.03.329_bib12","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1126\/science.1106830","article-title":"Myeloperoxidase, a leukocyte-derived vascular NO oxidase","volume":"296","author":"Eiserich","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jash.2014.03.329_bib13","first-page":"121","article-title":"Enzymatische Bestimmung des Gesamtcholesterins mit dem [Enzymatic dosage of total cholesterolemia by Greiner Selective Analyzer (GSA II)]","volume":"15","author":"Klose","year":"1978","journal-title":"J Clin Chem Clin Biochem"},{"key":"10.1016\/j.jash.2014.03.329_bib14","series-title":"Methods of Enzymatic Analysis","first-page":"18","article-title":"Triglycerides determination after enzymatic hydrolysis","author":"Wahlefeld","year":"1974"},{"key":"10.1016\/j.jash.2014.03.329_bib15","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI103182","article-title":"The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum","volume":"34","author":"Havel","year":"1955","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jash.2014.03.329_bib16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low density lipoprotein in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.jash.2014.03.329_bib17","first-page":"249","article-title":"Lipoprotein (a): structure, biology and clinical relevance","volume":"36","author":"Scanu","year":"1991","journal-title":"Adv Intern Med"},{"key":"10.1016\/j.jash.2014.03.329_bib18","first-page":"458","article-title":"Protein composition of lipoprotein (a)","volume":"80","author":"Uterman","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jash.2014.03.329_bib19","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1002\/eji.1830221226","article-title":"Cloning of TRAP, a ligand for CD40 on human T cells","volume":"22","author":"Graf","year":"1992","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jash.2014.03.329_bib20","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1016\/S0021-9258(18)61433-4","article-title":"Molecular cloning and characterization of cDNA for human myeloperoxidase","volume":"262","author":"Morishita","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jash.2014.03.329_bib21","series-title":"The Cytokine Handbook","author":"Zhang","year":"1988"},{"key":"10.1016\/j.jash.2014.03.329_bib22","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/clinchem\/45.12.2136","article-title":"Clinical efficacy of an automated high-sensitivity C-reactive protein assay","volume":"45","author":"Rifai","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.jash.2014.03.329_bib23","series-title":"Statistical Principles in Experimental Design","author":"Winer","year":"1971"},{"key":"10.1016\/j.jash.2014.03.329_bib24","first-page":"R1","article-title":"Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial","volume":"2","author":"Estacio","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jash.2014.03.329_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-122-2-199501150-00010","article-title":"Effects of antihypertensive therapy on serum lipids","volume":"122","author":"Kasiske","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jash.2014.03.329_bib26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s11906-000-0040-0","article-title":"Mechanism of differential effects of antihypertensive agents on serum lipids","volume":"2","author":"Brook","year":"2000","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jash.2014.03.329_bib27","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1097\/00005344-199312050-00016","article-title":"Serum lipoproteins during treatment with antihypertensive drugs","volume":"22","author":"Weidmann","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jash.2014.03.329_bib28","doi-asserted-by":"crossref","first-page":"26B","DOI":"10.1016\/0002-9149(91)90817-5","article-title":"Antihypertensive agents, serum lipoproteins and glucose metabolism","volume":"67","author":"Ferrari","year":"1991","journal-title":"Am J Cardiol"},{"issue":"6 Supp 7","key":"10.1016\/j.jash.2014.03.329_bib29","first-page":"VII43","article-title":"The effects of ACE inhibitors and other antihypertensive drugs on cardiovascular risk factors and atherogenesis","volume":"13","author":"Chobanian","year":"1990","journal-title":"Clin Cardiol"},{"issue":"5 Supp 1","key":"10.1016\/j.jash.2014.03.329_bib30","first-page":"38","article-title":"The role of altered lipid metabolism in the progression of renal disease: experimental evidence","volume":"17","author":"Keane","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jash.2014.03.329_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/sj.jhh.1001315","article-title":"Impact of an ACE inhibitor and calcium antagonist on microalbuminuria and lipid subfractions in type 2 diabetes: a randomised, multi-centre pilot study","volume":"16","author":"Bakris","year":"2002","journal-title":"J Hum Hypertens"}],"updated-by":[{"DOI":"10.1016\/j.jash.2015.08.013","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"record-id":"6164"},{"DOI":"10.1016\/j.jash.2014.03.329","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000}},{"DOI":"10.1016\/j.jash.2015.08.013","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000}}],"container-title":["Journal of the American Society of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193317111400446X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193317111400446X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:27:55Z","timestamp":1648744075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193317111400446X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S193317111400446X"],"URL":"https:\/\/doi.org\/10.1016\/j.jash.2014.03.329","relation":{},"ISSN":["1933-1711"],"issn-type":[{"value":"1933-1711","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Enalapril\/lercanidipine combination on markers of cardiovascular risk: a randomized study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jash.2014.03.329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}